Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 4/2017

03.03.2017 | General Gynecology

Management of device-related complications after sacral neuromodulation for lower urinary tract disorders in women: a single center experience

verfasst von: Tilemachos Kavvadias, Markus Huebner, Sara Yvonne Brucker, Christl Reisenauer

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study is aimed at presenting and discussing the device-related complication management during a 5-year period, of the sacral nerve modulation (SNM), in a tertiary-care university unit.

Methods

This is a retrospective chart review of all women, who received SNM in our department between May 2011 and May 2016. All two-stage procedures were performed by the same experienced surgeon and according to our strict protocol of patients’ selection and follow-up. Data of perioperative and postoperative complications and their management were collected.

Results

The test stimulation was positive in 59 out of 64 patients (92%), who then received the permanent implantation after a mean test phase duration of 9 days. Mean overall follow-up was 16.5 (±10.9) months. We recorded 20 complications (31%) in 15 patients, after a mean follow-up time of 160 days. These comprise: lead migration (13.8%), infection (8.6%), pain (5.2%), wound healing disorders (5.2%) and lead fibrosis (10%). The event/patient ratio was significantly reduced from 0.6 in the beginning of our experience with SNM to 0.2 at the second period of the study (p = 0.005). All complications could be successfully resolved after surgical intervention without influence on the treatment effect.

Conclusion

Complications after SNM are common and may require additional surgical intervention for full resolution but without affecting the treatment effect. Also, due to a learning curve, a lower events/patient ratio over time is to be expected.
Literatur
1.
Zurück zum Zitat Apostolidis A (2011) Neuromodulation for intractable OAB. Neurourol Urodynam 30:766–770CrossRef Apostolidis A (2011) Neuromodulation for intractable OAB. Neurourol Urodynam 30:766–770CrossRef
2.
3.
Zurück zum Zitat Brazzelli M, Murray A, Fraser C (2006) Efficacy and safety of sacral nerve stimulation for urinary urge incontinence; a systematic review. J Urol 175:835–841CrossRefPubMed Brazzelli M, Murray A, Fraser C (2006) Efficacy and safety of sacral nerve stimulation for urinary urge incontinence; a systematic review. J Urol 175:835–841CrossRefPubMed
4.
Zurück zum Zitat Peeters K, Sahai A, De Ridder D, Van Der Aa F (2014) Long-term follow-up of sacral neuromodulation for lower urinary tract dysfunction. BJU Int 113:789–794CrossRefPubMed Peeters K, Sahai A, De Ridder D, Van Der Aa F (2014) Long-term follow-up of sacral neuromodulation for lower urinary tract dysfunction. BJU Int 113:789–794CrossRefPubMed
5.
Zurück zum Zitat Cappellano F, Bertapelle P, Spinelli M, Catanzaro F, Carone R, Zanollo A, De Seta F, Giardiello G (2001) Quality of life assessment in patients who undergo sacral neuromodulation implantation for urge incontinence: an additional tool for evaluating outcome. J Urol 166(6):2277–2280CrossRefPubMed Cappellano F, Bertapelle P, Spinelli M, Catanzaro F, Carone R, Zanollo A, De Seta F, Giardiello G (2001) Quality of life assessment in patients who undergo sacral neuromodulation implantation for urge incontinence: an additional tool for evaluating outcome. J Urol 166(6):2277–2280CrossRefPubMed
7.
Zurück zum Zitat Siegel S, Noblett K, Mangel J, Griebling TL, Sutherland SE, Bird ET, Comiter C, Culkin D, Bennett J, Zylstra S, Kan F, Thiery E (2016) Three-year follow-up results of a prospective, multicenter study in overactive bladder subjects treated with sacral neuromodulation. Urology. doi:10.1016/j.urology.2016.04.024 Siegel S, Noblett K, Mangel J, Griebling TL, Sutherland SE, Bird ET, Comiter C, Culkin D, Bennett J, Zylstra S, Kan F, Thiery E (2016) Three-year follow-up results of a prospective, multicenter study in overactive bladder subjects treated with sacral neuromodulation. Urology. doi:10.​1016/​j.​urology.​2016.​04.​024
8.
Zurück zum Zitat Peters KM, Killinger KA, Gilleran JP, Bartley J, Wolfert C, Boura JA (2015) Predictors of reoperation after sacral neuromodulation: a single institution evaluation of over 400 patients. Neurourol Urodyn. doi:10.1002/nau.22929 Peters KM, Killinger KA, Gilleran JP, Bartley J, Wolfert C, Boura JA (2015) Predictors of reoperation after sacral neuromodulation: a single institution evaluation of over 400 patients. Neurourol Urodyn. doi:10.​1002/​nau.​22929
9.
Zurück zum Zitat Gormley EA, Lightner DJ, Faraday M, Vasavada SP (2015) Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment. J Urol 193:1572–1580CrossRefPubMed Gormley EA, Lightner DJ, Faraday M, Vasavada SP (2015) Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment. J Urol 193:1572–1580CrossRefPubMed
10.
Zurück zum Zitat Siegel SW, Catanzaro F, Dijkema HE, Elhilali MM, Fowler CJ, Gajewski JB, Hassouna MM, Janknegt RA, Jonas U, Van Kerrebroeck PE, Lycklama a Nijeholt AA, Oleson KA, Schmidt RA (2000) Long-term results of a multicenter study on sacral nerve stimulation for treatment of urinary urge incontinence, urgency-frequency and retention. Urology 56(6 Suppl 1):87–91CrossRefPubMed Siegel SW, Catanzaro F, Dijkema HE, Elhilali MM, Fowler CJ, Gajewski JB, Hassouna MM, Janknegt RA, Jonas U, Van Kerrebroeck PE, Lycklama a Nijeholt AA, Oleson KA, Schmidt RA (2000) Long-term results of a multicenter study on sacral nerve stimulation for treatment of urinary urge incontinence, urgency-frequency and retention. Urology 56(6 Suppl 1):87–91CrossRefPubMed
11.
Zurück zum Zitat Siddiqui N, Amundsen C, Corey E, Wu J (2011) Lead migration after sacral neuromodulation: surgical revision in fascial versus tined anchoring systems. Int Urogynecol J 22:419–423CrossRefPubMed Siddiqui N, Amundsen C, Corey E, Wu J (2011) Lead migration after sacral neuromodulation: surgical revision in fascial versus tined anchoring systems. Int Urogynecol J 22:419–423CrossRefPubMed
12.
Zurück zum Zitat Al-Zahrani A, Elzayat E, Gajewski J (2011) Long-term outcome and surgical interventions after sacral neuromodulation implant for lower urinary tract symptoms: 14-year experience at 1 center. J Urol 185:981–986CrossRefPubMed Al-Zahrani A, Elzayat E, Gajewski J (2011) Long-term outcome and surgical interventions after sacral neuromodulation implant for lower urinary tract symptoms: 14-year experience at 1 center. J Urol 185:981–986CrossRefPubMed
13.
Zurück zum Zitat Van Voskuilen AC, Oerlemans DJ, Weil EH et al (2006) Long term results of neuromodulation by sacral nerve stimulation for lower urinary tract symptoms: a retrospective single center study. Eur Urol 49:366–372CrossRefPubMed Van Voskuilen AC, Oerlemans DJ, Weil EH et al (2006) Long term results of neuromodulation by sacral nerve stimulation for lower urinary tract symptoms: a retrospective single center study. Eur Urol 49:366–372CrossRefPubMed
14.
Zurück zum Zitat Gaynor-Krupnick D, Dwyer N, Rittenmeyer H, Kreder K (2006) Evaluation and management of malfunctioning sacral neuromodulator. Urology 67:246–249CrossRefPubMed Gaynor-Krupnick D, Dwyer N, Rittenmeyer H, Kreder K (2006) Evaluation and management of malfunctioning sacral neuromodulator. Urology 67:246–249CrossRefPubMed
15.
Zurück zum Zitat Wexner S, Hull T, Edden Y, Coller J, Devroede G, McCallum, Chan M, Ayscue J, Shobeiri A, Margolin D, England M, Kaufman H, Snape W, Mutlu E, Chua H, Pettit P, Nagle D, Madoff R, Lerew D, Mellgren D (2010) Infection rates in a large investigational trial of sacral nerve stimulation for fecal incontinence. J Gastrointest Surg 14:1081–1089CrossRefPubMed Wexner S, Hull T, Edden Y, Coller J, Devroede G, McCallum, Chan M, Ayscue J, Shobeiri A, Margolin D, England M, Kaufman H, Snape W, Mutlu E, Chua H, Pettit P, Nagle D, Madoff R, Lerew D, Mellgren D (2010) Infection rates in a large investigational trial of sacral nerve stimulation for fecal incontinence. J Gastrointest Surg 14:1081–1089CrossRefPubMed
16.
Zurück zum Zitat Hijaz A, Vasavada S, Daneshgari F, Frinjari, Goldman H, Rackley R (2006) Complications and troubleshooting of two-stage sacral neuromodulation therapy: a single-institution experience. Urology 68:533–537CrossRefPubMed Hijaz A, Vasavada S, Daneshgari F, Frinjari, Goldman H, Rackley R (2006) Complications and troubleshooting of two-stage sacral neuromodulation therapy: a single-institution experience. Urology 68:533–537CrossRefPubMed
17.
Zurück zum Zitat White WM, Mobley JD III, Doggweiler R, Dobmeyer-Dittrich C, Klein FA (2009) Incidence and predictors of complications with sacral neuromodulation. Urology 73:731–735CrossRefPubMed White WM, Mobley JD III, Doggweiler R, Dobmeyer-Dittrich C, Klein FA (2009) Incidence and predictors of complications with sacral neuromodulation. Urology 73:731–735CrossRefPubMed
Metadaten
Titel
Management of device-related complications after sacral neuromodulation for lower urinary tract disorders in women: a single center experience
verfasst von
Tilemachos Kavvadias
Markus Huebner
Sara Yvonne Brucker
Christl Reisenauer
Publikationsdatum
03.03.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 4/2017
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-017-4303-2

Weitere Artikel der Ausgabe 4/2017

Archives of Gynecology and Obstetrics 4/2017 Zur Ausgabe

Ambulantisierung: Erste Erfahrungen mit dem Hybrid-DRG

02.05.2024 DCK 2024 Kongressbericht

Die Hybrid-DRG-Verordnung soll dazu führen, dass mehr chirurgische Eingriffe ambulant durchgeführt werden, wie es in anderen Ländern schon länger üblich ist. Die gleiche Vergütung im ambulanten und stationären Sektor hatten Niedergelassene schon lange gefordert. Aber die Umsetzung bereitet ihnen doch Kopfzerbrechen.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Harninkontinenz: Netz-Op. erfordert über lange Zeit intensive Nachsorge

30.04.2024 Harninkontinenz Nachrichten

Frauen mit Belastungsinkontinenz oder Organprolaps sind nach einer Netz-Operation keineswegs beschwerdefrei. Vielmehr scheint die Krankheitslast weiterhin hoch zu sein, sogar höher als von harninkontinenten Frauen, die sich nicht haben operieren lassen.

Welche Übungen helfen gegen Diastase recti abdominis?

30.04.2024 Schwangerenvorsorge Nachrichten

Die Autorinnen und Autoren einer aktuellen Studie aus Griechenland sind sich einig, dass Bewegungstherapie, einschließlich Übungen zur Stärkung der Bauchmuskulatur und zur Stabilisierung des Rumpfes, eine Diastase recti abdominis postpartum wirksam reduzieren kann. Doch vieles ist noch nicht eindeutig belegt.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.